Nicola Klein to Poliovirus Vaccine, Inactivated
This is a "connection" page, showing publications Nicola Klein has written about Poliovirus Vaccine, Inactivated.
Connection Strength
2.326
-
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers. Vaccine. 2016 07 29; 34(35):4172-4179.
Score: 0.545
-
An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children. Vaccine. 2012 Jan 11; 30(3):668-74.
Score: 0.394
-
Preterm infants' T cell responses to inactivated poliovirus vaccine. J Infect Dis. 2010 Jan 15; 201(2):214-22.
Score: 0.348
-
Kinrix: a new combination DTaP-IPV vaccine for children aged 4-6 years. Expert Rev Vaccines. 2008 Nov; 7(9):1309-20.
Score: 0.320
-
Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age. Pediatr Infect Dis J. 2008 Apr; 27(4):341-6.
Score: 0.308
-
Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants. Pediatr Infect Dis J. 2017 02; 36(2):202-208.
Score: 0.142
-
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
Score: 0.116
-
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013 Jan 15; 177(2):131-41.
Score: 0.107
-
Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial. Vaccine. 2021 03 05; 39(10):1534-1543.
Score: 0.046